108 related articles for article (PubMed ID: 27879994)
1. A new mutation of ANO6 in two familial cases of Scott syndrome.
Boisseau P; Bene MC; Besnard T; Pachchek S; Giraud M; Talarmain P; Robillard N; Gourlaouen MA; Bezieau S; Fouassier M
Br J Haematol; 2018 Mar; 180(5):750-752. PubMed ID: 27879994
[No Abstract] [Full Text] [Related]
2. Gene of the issue:
Millington-Burgess SL; Harper MT
Platelets; 2020 Oct; 31(7):964-967. PubMed ID: 31746257
[No Abstract] [Full Text] [Related]
3. Survival protein anoctamin-6 controls multiple platelet responses including phospholipid scrambling, swelling, and protein cleavage.
Mattheij NJ; Braun A; van Kruchten R; Castoldi E; Pircher J; Baaten CC; Wülling M; Kuijpers MJ; Köhler R; Poole AW; Schreiber R; Vortkamp A; Collins PW; Nieswandt B; Kunzelmann K; Cosemans JM; Heemskerk JW
FASEB J; 2016 Feb; 30(2):727-37. PubMed ID: 26481309
[TBL] [Abstract][Full Text] [Related]
4. Molecular functions of anoctamin 6 (TMEM16F): a chloride channel, cation channel, or phospholipid scramblase?
Kunzelmann K; Nilius B; Owsianik G; Schreiber R; Ousingsawat J; Sirianant L; Wanitchakool P; Bevers EM; Heemskerk JW
Pflugers Arch; 2014 Mar; 466(3):407-14. PubMed ID: 23748496
[TBL] [Abstract][Full Text] [Related]
5. Calcium-activated and apoptotic phospholipid scrambling induced by Ano6 can occur independently of Ano6 ion currents.
Kmit A; van Kruchten R; Ousingsawat J; Mattheij NJ; Senden-Gijsbers B; Heemskerk JW; Schreiber R; Bevers EM; Kunzelmann K
Cell Death Dis; 2013 Apr; 4(4):e611. PubMed ID: 23618909
[TBL] [Abstract][Full Text] [Related]
6. Ca
Roh JW; Hwang GE; Kim WK; Nam JH
Mol Cells; 2021 Feb; 44(2):88-100. PubMed ID: 33658434
[TBL] [Abstract][Full Text] [Related]
7. Temperature-dependent increase in the calcium sensitivity and acceleration of activation of ANO6 chloride channel variants.
Lin H; Jun I; Woo JH; Lee MG; Kim SJ; Nam JH
Sci Rep; 2019 Apr; 9(1):6706. PubMed ID: 31040335
[TBL] [Abstract][Full Text] [Related]
8. A TMEM16F point mutation causes an absence of canine platelet TMEM16F and ineffective activation and death-induced phospholipid scrambling.
Brooks MB; Catalfamo JL; MacNguyen R; Tim D; Fancher S; McCardle JA
J Thromb Haemost; 2015 Dec; 13(12):2240-52. PubMed ID: 26414452
[TBL] [Abstract][Full Text] [Related]
9. Platelet membrane phospholipid asymmetry: from the characterization of a scramblase activity to the identification of an essential protein mutated in Scott syndrome.
Lhermusier T; Chap H; Payrastre B
J Thromb Haemost; 2011 Oct; 9(10):1883-91. PubMed ID: 21958383
[TBL] [Abstract][Full Text] [Related]
10. Anoctamin-6 controls bone mineralization by activating the calcium transporter NCX1.
Ousingsawat J; Wanitchakool P; Schreiber R; Wuelling M; Vortkamp A; Kunzelmann K
J Biol Chem; 2015 Mar; 290(10):6270-80. PubMed ID: 25589784
[TBL] [Abstract][Full Text] [Related]
11. Anoctamin 6 differs from VRAC and VSOAC but is involved in apoptosis and supports volume regulation in the presence of Ca2+.
Juul CA; Grubb S; Poulsen KA; Kyed T; Hashem N; Lambert IH; Larsen EH; Hoffmann EK
Pflugers Arch; 2014 Oct; 466(10):1899-910. PubMed ID: 24419539
[TBL] [Abstract][Full Text] [Related]
12. Expression of proteins controlling transbilayer movement of plasma membrane phospholipids in the B lymphocytes from a patient with Scott syndrome.
Zhou Q; Sims PJ; Wiedmer T
Blood; 1998 Sep; 92(5):1707-12. PubMed ID: 9716599
[TBL] [Abstract][Full Text] [Related]
13. Roles and regulation of phospholipid scramblases.
Kodigepalli KM; Bowers K; Sharp A; Nanjundan M
FEBS Lett; 2015 Jan; 589(1):3-14. PubMed ID: 25479087
[TBL] [Abstract][Full Text] [Related]
14. Regulatory Roles of Anoctamin-6 in Human Trabecular Meshwork Cells.
Banerjee J; Leung CT; Li A; Peterson-Yantorno K; Ouyang H; Stamer WD; Civan MM
Invest Ophthalmol Vis Sci; 2017 Jan; 58(1):492-501. PubMed ID: 28125837
[TBL] [Abstract][Full Text] [Related]
15. Anoctamin 6 mediates effects essential for innate immunity downstream of P2X7 receptors in macrophages.
Ousingsawat J; Wanitchakool P; Kmit A; Romao AM; Jantarajit W; Schreiber R; Kunzelmann K
Nat Commun; 2015 Feb; 6():6245. PubMed ID: 25651887
[TBL] [Abstract][Full Text] [Related]
16. Compound heterozygosity for 2 novel TMEM16F mutations in a patient with Scott syndrome.
Castoldi E; Collins PW; Williamson PL; Bevers EM
Blood; 2011 Apr; 117(16):4399-400. PubMed ID: 21511967
[No Abstract] [Full Text] [Related]
17. Ion channel and lipid scramblase activity associated with expression of TMEM16F/ANO6 isoforms.
Scudieri P; Caci E; Venturini A; Sondo E; Pianigiani G; Marchetti C; Ravazzolo R; Pagani F; Galietta LJ
J Physiol; 2015 Sep; 593(17):3829-48. PubMed ID: 26108457
[TBL] [Abstract][Full Text] [Related]
18. Assessment of the expression of candidate human plasma membrane phospholipid scramblase in Scott syndrome cells.
Janel N; Leroy C; Laude I; Toti F; Fressinaud E; Meyer D; Freyssinet JM; Kerbiriou-Nabias D
Thromb Haemost; 1999 Feb; 81(2):322-3. PubMed ID: 10064019
[No Abstract] [Full Text] [Related]
19. Uneventful coronary artery bypass surgery without prophylactic replacement therapy in a patient with a novel heterozygous FVII gene deletion.
Gallinaro L; Casonato A; Vianello F; Fadin M; Cella G
Haemophilia; 2009 Sep; 15(5):1171-3. PubMed ID: 19558489
[No Abstract] [Full Text] [Related]
20. Scott syndrome erythrocytes contain a membrane protein capable of mediating Ca2+-dependent transbilayer migration of membrane phospholipids.
Stout JG; Bassé F; Luhm RA; Weiss HJ; Wiedmer T; Sims PJ
J Clin Invest; 1997 May; 99(9):2232-8. PubMed ID: 9151796
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
